Catalyst Pharmaceuticals (CPRX) had the highest return in 2019 and on May 15, 2019 by a mid-cap US stock, returning 11.7%.
| ASSET | % RETURN |
|---|---|
Catalyst Pharmaceuticals (CPRX) | 11.67% |
HUTCHMED DRC (HCM) | 10% |
GDS (GDS) | 9.7% |
Nextdecade (NEXT) | 8.89% |
Coty (COTY) | 8.67% |
Inspire Medical Systems (INSP) | 8.01% |
LYFT (LYFT) | 7.65% |
Amdocs (DOX) | 7.57% |
Guardant Health (GH) | 7.57% |
Twist Bioscience (TWST) | 7.11% |
Option Care Health (OPCH) | 6.67% |
Denali Therapeutics (DNLI) | 6.62% |
Etsy (ETSY) | 6.61% |
PagSeguro Digital (PAGS) | 6.48% |
Oceaneering International (OII) | 5.98% |
Veracyte (VCYT) | 5.94% |
Kratos Defense & Security Solutions (KTOS) | 5.68% |
Altair Engineering (ALTR) | 5.43% |
Corporacion America Airports (CAAP) | 5.4% |
Frontline (FRO) | 5.39% |
Victory Capital (VCTR) | 5.32% |
Seaboard (SEB) | 5.21% |
Impinj (PI) | 5.2% |
Caesars Entertainment (CZR) | 5.12% |
Northern Oil & Gas (NOG) | 5.09% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
